Premature Infants Receiving Cord Milking Or Delayed Cord Clamping

接受脐带挤奶或延迟断脐的早产儿

基本信息

  • 批准号:
    9310473
  • 负责人:
  • 金额:
    $ 63.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

BACKGROUND: Preterm brain injury from intraventricular hemorrhage (IVH) is a pressing worldwide public health problem. Over 12,000 premature newborns develop IVH every year in the US alone. Delaying clamping the umbilical cord at birth for 30-60 seconds provides the newborn with a significant autologous transfusion of blood from the placenta and has been shown to reduce IVH. Delayed cord clamping (DCC) has been shown to reduce overall IVH (mainly lower grades 1 and 2) by 50 percent, but has not reduced the incidence of severe IVH or death. This may reflect inadequate placental transfusion for newborns delivered by Cesarean section (C/S), the most common mode of delivery for very preterm infants. In 3 DCC trials an increased placental transfusion was evident in infants born by vaginal delivery (V/D), but no or minimal transfusion in infants delivered by C/S. We evaluated a technique – umbilical cord milking (UCM) – which provides a placental transfusion by grasping the unclamped umbilical cord and pushing blood towards the newborn several times before the cord is clamped. Our Phase 1 pilot trial (PREMOD) compared UCM to DCC in premature newborns delivered by C/S and V/D. Results were equivalent for V/D. UCM improved blood flow and organ perfusion in C/S infants. SPECIFIC AIMS: The specific aims of this trial are: Aim 1. To compare the incidence of severe IVH and/or death in premature newborns <32 weeks GA delivered by C/S receiving UCM to those receiving DCC. Aim 2. To compare the safety and efficacy profiles of premature newborns <32 weeks GA delivered by C/S receiving UCM vs. DCC during their hospitalization and at 24 months corrected age. Aim 3. To compare the outcomes of premature newborns <32 weeks GA delivered by C/S (from Aims 1 and 2) with those born by V/D receiving UCM or DCC. DESIGN: This trial has a 2-tiered approach that will first demonstrate that the incidence of severe IVH and/or death in premature newborns <32 weeks delivered by C/S with UCM is equivalent to DCC (non-inferiority), and then test whether there is a decreased incidence of severe IVH and/or death with UCM (superiority). This approach is being used in other neonatal trials, is endorsed by the FDA, and can be done within the scope and sample of the proposed trial. DCC: The obstetrician will wait at least 60 seconds to clamp the cord. UCM: The obstetrician will milk about 20 cm of umbilical cord four times over 2 seconds each. Brain oxygenation will be recorded for the first 72 hours of life. Outcomes will include resuscitation interventions and neurodevelopmental follow-up at 2 years. UCM is simple and allows resuscitation of the most critical infants without delay, which justifies its use, even if UCM is equivalent to DCC. Optimal umbilical cord management in premature newborns is an area that urgently needs scientific evidence to establish clear guidelines worldwide.
背景:脑室内出血(IVH)引起的早产儿脑损伤是一个紧迫的全球公众问题, 健康问题。仅在美国,每年就有超过12,000名早产儿发生IVH。延迟箝位 出生时脐带30-60秒为新生儿提供了显著的自体输血, 胎盘的血液,并已被证明可以减少IVH。延迟脊髓夹持(DCC)已被证明 将总体IVH(主要是1级和2级以下)减少50%,但没有减少严重IVH的发生率。 IVH或死亡。这可能反映了剖宫产新生儿胎盘输血不足 (C/S),这是极早产儿最常见的分娩方式。在3项DCC试验中, 输血在阴道分娩(V/D)的婴儿中很明显,但在分娩的婴儿中没有或很少输血 C/S。我们评估了一种技术-脐带挤奶(UCM)-提供胎盘输血, 抓住未夹紧的脐带,在脐带被剪断之前将血液推向新生儿几次。 夹紧。我们的1期先导试验(PREMOD)比较了UCM和DCC在C/S分娩的早产儿中的作用 V/D。V/D的结果等同。UCM改善C/S婴儿的血流和器官灌注。 具体目的:本试验的具体目的是: 目标1。比较GA分娩<32周早产儿严重IVH和/或死亡的发生率 通过C/S接收UCM到那些接收DCC。 目标2.比较C/S分娩<32周GA早产儿的安全性和有效性 在住院期间和24个月矫正年龄时接受UCM与DCC。 目标3.比较通过C/S分娩的<32周GA早产儿的结局(来自目标1和2) 出生于V/D的人接受UCM或DCC。 设计:本试验采用两层方法,首先证明严重IVH和/或 C/S联合UCM分娩的<32周早产儿的死亡率与DCC相当(非劣效性), 然后检验UCM是否降低了严重IVH和/或死亡的发生率(优效性)。这 这种方法正在其他新生儿试验中使用,得到了FDA的认可,可以在范围内完成, 拟议试验的样本。DCC:产科医生至少要等60秒才能夹住脐带。UCM:The 产科医生将在2秒内抽取约20厘米的脐带四次。大脑氧合会 出生后72小时内的记录。结果将包括复苏干预和神经发育 随访2年。UCM是简单的,并允许复苏的最关键的婴儿没有延误, 即使UCM等同于DCC,也证明其使用是合理的。早产儿的最佳脐带管理 这是一个迫切需要科学证据来在全球范围内建立明确指导方针的领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anup C Katheria其他文献

Anup C Katheria的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anup C Katheria', 18)}}的其他基金

Sharp Neonatal Research Institute Clinical Center (Sharp NRI-CC)
夏普新生儿研究所临床中心 (Sharp NRI-CC)
  • 批准号:
    10683030
  • 财政年份:
    2023
  • 资助金额:
    $ 63.43万
  • 项目类别:
Delayed Cord Clamping with Oxygen In Extremely Low Gestational Age Infants (DOXIE)
极低胎龄婴儿延迟供氧断脐 (DOXIE)
  • 批准号:
    10549378
  • 财政年份:
    2022
  • 资助金额:
    $ 63.43万
  • 项目类别:
Delayed Cord Clamping with Oxygen In Extremely Low Gestational Age Infants (DOXIE)
极低胎龄婴儿延迟供氧断脐 (DOXIE)
  • 批准号:
    10373881
  • 财政年份:
    2022
  • 资助金额:
    $ 63.43万
  • 项目类别:
The NICU Antibiotics and Outcomes (NANO) Trial
NICU 抗生素和结果 (NANO) 试验
  • 批准号:
    10213792
  • 财政年份:
    2019
  • 资助金额:
    $ 63.43万
  • 项目类别:
The NICU Antibiotics and Outcomes (NANO) Trial
NICU 抗生素和结果 (NANO) 试验
  • 批准号:
    10677891
  • 财政年份:
    2019
  • 资助金额:
    $ 63.43万
  • 项目类别:
The NICU Antibiotics and Outcomes (NANO) Trial
NICU 抗生素和结果 (NANO) 试验
  • 批准号:
    10457371
  • 财政年份:
    2019
  • 资助金额:
    $ 63.43万
  • 项目类别:
The NICU Antibiotics and Outcomes (NANO) Trial
NICU 抗生素和结果 (NANO) 试验
  • 批准号:
    10018511
  • 财政年份:
    2019
  • 资助金额:
    $ 63.43万
  • 项目类别:
Umbilical Cord Milking in Non Vigorous Infants (the MINVI Trial)
非活力婴儿的脐带挤奶(MINVI 试验)
  • 批准号:
    10401868
  • 财政年份:
    2018
  • 资助金额:
    $ 63.43万
  • 项目类别:
Umbilical Cord Milking in Non Vigorous Infants (the MINVI Trial)
非活力婴儿的脐带挤奶(MINVI 试验)
  • 批准号:
    10188576
  • 财政年份:
    2018
  • 资助金额:
    $ 63.43万
  • 项目类别:
Premature Infants Receiving Cord Milking Or Delayed Cord Clamping
接受脐带挤奶或延迟断脐的早产儿
  • 批准号:
    9914830
  • 财政年份:
    2017
  • 资助金额:
    $ 63.43万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341426
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341424
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政​​策的情绪动态
  • 批准号:
    10108433
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
  • 批准号:
    24K13490
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
  • 批准号:
    EP/Z00022X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
  • 批准号:
    MR/Y003365/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
  • 批准号:
    2335955
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
  • 批准号:
    AH/Y007549/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了